Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 211 (2) , 162-170
Abstract
No abstract availableKeywords
Funding Information
- Chung-Ang University
This publication has 29 references indexed in Scilit:
- BRAF V600E mutation detection by immunohistochemistry in colorectal carcinomaGenes, Chromosomes and Cancer, 2013
- Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization MethodAmerican Journal of Surgical Pathology, 2012
- Epidural intracranial metastasis from benign leiomyoma: A case report with literature reviewClinical Neurology and Neurosurgery, 2012
- BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid CancerAnnals of Surgical Oncology, 2012
- BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid CancerWorld Journal of Surgery, 2011
- Clinical Risk Factors Associated with Cervical Lymph Node Recurrence in Papillary Thyroid CarcinomaThyroid®, 2010
- The Prevalence and Prognostic Value of BRAF Mutation in Thyroid CancerAnnals of Surgery, 2007
- Guilty as chargedCancer Cell, 2004
- Mutations of the BRAF gene in human cancerNature, 2002
- Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumorsOncogene, 1999